TGTX Price Prediction Next Week
Analysis and Insights
Fundamental Analysis:
TG Therapeutics (TGTX) has shown strong performance recently, driven by the success of its product Briumvi, which saw a 200% year-over-year increase in sales to $313 million. The company is targeting $540 million in sales for this year, indicating high growth potential. Earnings estimates for the upcoming quarter have been revised 127.5% higher, suggesting strong investor confidence.
Technical Analysis:
The stock is currently trading at $40.94 with a bullish trend. Key technical indicators include:
- RSI (6-period): 79.33, indicating overbought conditions but still in an uptrend.
- MACD: Positive at 2.04, showing strong upward momentum.
- Fibonacci Levels: Resistance at $40.82 and $43.55, with support at $36.40.
Options Activity:
Bullish options activity has been observed, with 2,450 calls traded and increasing implied volatility to 63.04%. This indicates strong investor interest ahead of earnings on May 8th.
Conclusion:
Given the strong fundamentals, positive earnings revisions, and bullish options activity, the stock is expected to continue its upward trend. However, the overbought RSI suggests a potential short-term pullback. The next resistance level at $43.55 is a key target.
Prediction: The stock price is expected to reach $43.20 in the next trading week. Buy recommendation, as the overall trend remains bullish despite minor corrections.
TGTX Similar Chart Price Prediction
The price of TGTX is predicted to go up -21.26%, based on the high correlation periods with DMAC. The similarity of these two price pattern on the periods is 96.82%.

TGTX

DMAC
TGTX Revenue Forecast
TGTX EPS Forecast
TGTX FAQs
What is TGTX revenue forecast for next quarter?
The market consensus for TGTX's revenue in the upcoming quarter is projected to be approximately $117.073M USD.
TGTX Analyst's Forecast
Eric Joseph
JP Morgan
2024-11-25
Price Target
$30 → $43
Upside
+24.24%
Tara Bancroft
TD Cowen
2024-10-29
Price Target
$50
Upside
+94.48%